Skip to main content

Reporter Oct 7 2022

Skin pigment affects oxygen monitor

Oct. 11, 2022—Black patients in the ICU were more likely to have low or high blood oxygen levels than white patients, even when a pulse oximeter indicated 92-96% oxygen saturation, Vanderbilt researchers found.

Read more


Opening a window to glaucoma

Oct. 10, 2022—A metalloprotease enzyme plays an important role in retinal ganglion cell development, Vanderbilt researchers discovered; studying it and other family members may lead to the identification of novel targets for treating glaucoma.

Read more


Vanderbilt’s Crowe receives the Building the Foundation Award from Research!America

Oct. 6, 2022—Vanderbilt's James Crowe Jr., MD, has received the Building the Foundation Award from Research!America, a national biomedical research advocacy organization.

Read more


Gene tied to childhood epilepsy

Oct. 6, 2022—Data drawn from four unrelated patients with a childhood epilepsy syndrome — and from in vitro and in vivo studies — link novel variants in a GABA transporter gene to seizure activity, Vanderbilt researchers reported.

Read more


Gregory inducted into Tennessee Health Care Hall of Fame

Oct. 6, 2022—Vanderbilt's David Gregory, MD, associate professor of Medicine, emeritus, is among five honorees who will be inducted Oct. 18 to the Tennessee Health Care Hall of Fame.

Read more


Stress, obesity and food intake

Oct. 6, 2022—Vanderbilt researchers are elucidating the neuronal pathways that contribute to food consumption in response to stress — “comfort feeding” — and how they differ in males versus females and in the context of obesity.

Read more


Study finds that reducing intake of simple sugars improves GERD

Oct. 6, 2022—A Vanderbilt study found that reducing dietary carbohydrates improved both symptoms and objective measurements of gastroesophageal reflux disease (GERD) in a randomized controlled trial.

Read more


VUMC to test whether Alzheimer’s drug can ease lupus symptoms

Oct. 6, 2022—Vanderbilt University Medical Center is partnering with Evergreen Therapeutics Inc. to test whether an Alzheimer’s drug, memantine, can improve cognitive symptoms associated with systemic lupus.

Read more


Audio recordings could benefit older adults following clinic visits

Oct. 6, 2022—Vanderbilt researchers are studying the impact of sharing audio recordings of their visits with older adults who have diabetes.

Read more


Flulapalooza

Oct. 6, 2022—Nearly 10,000 faculty, staff, postdoc scholars and students were vaccinated at last week’s Flulapalooza event.

Read more


Kidney diseases research collaboration renewed

Oct. 6, 2022—Vanderbilt University Medical Center and Bayer have agreed to continue a strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases.

Read more


VWCH adds epilepsy monitoring unit, onsite neurologist

Oct. 6, 2022—Vanderbilt Wilson County Hospital has added an epilepsy monitoring unit (EMU), with a neurologist onsite seeing patients in the hospital.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more